Architect i2000SR Analyser System
Device
Abbott Laboratories
Total Payments
$4.1M
Transactions
271
Doctors
44
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4.1M | 271 | 44 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.6M | 187 | 88.1% |
| Consulting Fee | $300,879 | 13 | 7.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,752 | 27 | 3.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $14,030 | 1 | 0.3% |
| Long term medical supply or device loan | $10,645 | 3 | 0.3% |
| Travel and Lodging | $3,036 | 9 | 0.1% |
| Food and Beverage | $1,977 | 31 | 0.0% |
Payments by Type
Research
$3.6M
187 transactions
General
$488,319
84 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CRA Second Amendment-CAD Study | Abbott Laboratories | $687,000 | 0 |
| Alinity s Anti-HCV II Clinical Evaluation Protocol | Abbott Laboratories | $676,005 | 0 |
| Viral surveillance and discovery in Chicago | Abbott Laboratories | $325,800 | 0 |
| Using hs-cTnI and NT-proBNP to Personalize Blood Pressure Treatment Goals: A Systolic Blood Pressure Intervention Trial (SPRINT) Substudy | Abbott Laboratories | $249,374 | 0 |
| TRACK-TBI | Abbott Laboratories | $223,975 | 0 |
| Architect Stat High Sensitive Troponin-I Screening for full ARIC cohort | Abbott Laboratories | $203,008 | 0 |
| Biomarkers for the Prediction Incident Heart Failure and Cardiovascular Disease in Patients Undergoing Coronary or Peripheral Angiography in the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study | Abbott Laboratories | $140,000 | 0 |
| Transforming Research and Clinical Knowledge in Traumatic Brain Injury | Abbott Laboratories | $100,000 | 0 |
| Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure: PEARL-HF study | Abbott Laboratories | $93,748 | 0 |
| Evaluation of In Vitro T cell responses to SATS-CoV-2 proteins among individuals who have recovered from COVID-19 | Abbott Laboratories | $88,344 | 0 |
| Prediction of Cancer Therapeutics Related Cardiac Dysfunction and Major Adverse Cardiovascular Events in Cancer patients treated with potentially Cardiotoxic Agents | Abbott Laboratories | $80,000 | 0 |
| Performance Evaluation of Architect SARS-CoV-2 IgG & IgM vs Alinity SARS-CoV-2 IgG & IgM | Abbott Laboratories | $72,464 | 0 |
| Abbott Brainstorm Medical Phase I data analysis protocol | Abbott Laboratories | $66,900 | 0 |
| Beaumont Health Large-scale automated Serologic Testing for COVID-19 Vaccination Elicited Response | Abbott Laboratories | $65,000 | 0 |
| Evaluation of biomarkers from individuals who have recovered from COVID-19 | Abbott Laboratories | $60,000 | 0 |
| Investigating Household Transmission (HOVER-HBV) and Characterization of Childhood Hepatitis B (K08) in the Democratic Republic of the Congo | Abbott Laboratories | $54,012 | 0 |
| (EMS Time Machine) Prehospital Blood Collection to Reduce Sepsis | Abbott Laboratories | $40,000 | 0 |
| Evaluation of the durability of SARS-CoV-2 vaccine-induced antibodies (VAB) | Abbott Laboratories | $40,000 | 0 |
| MINERVA Biomarkers Substudy | Abbott Laboratories | $40,000 | 0 |
| Evaluation of potential injury in patients with influenza A, influenza B or SARS-CoV-2 | Abbott Laboratories | $33,501 | 0 |
Top Doctors Receiving Payments for Architect i2000SR Analyser System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tulsa, OK | $3.8M | 218 |
| , D.O | Family Medicine | Boston, MA | $270,000 | 2 |
| , MD | Cardiovascular Disease | Solana Beach, CA | $18,670 | 2 |
| , MD | Internal Medicine | Houston, TX | $4,800 | 1 |
| , M.D | Emergency Medicine | Rochester, NY | $4,725 | 2 |
| , D.O | Hematology | Columbus, OH | $2,250 | 1 |
| , M.D | Emergency Medical Services | Detroit, MI | $2,025 | 1 |
| , MD | Specialist | Atherton, CA | $1,275 | 1 |
| , MD | Specialist | Newark, DE | $1,053 | 2 |
| , MD | Blood Banking & Transfusion Medicine | Wellesley, MA | $1,000 | 1 |
| , PA-C | Physician Assistant | Newark, DE | $804.51 | 3 |
| , M.D | Internal Medicine | San Diego, CA | $735.00 | 1 |
| , M.D | Emergency Medicine | Winston Salem, NC | $700.00 | 1 |
| , APRN, FNP | Family | Ashland, OR | $612.55 | 2 |
| , M.D | Anesthesiology | Medford, OR | $566.55 | 2 |
| , MD | Emergency Medicine | Mount Vernon, OH | $159.78 | 1 |
| , ARNP, FNP | Registered Nurse | Sandy, UT | $159.77 | 1 |
| , M.D., PH.D | Emergency Medicine | Ann Arbor, MI | $129.98 | 2 |
| , M.D | Family Medicine | Oklahoma City, OK | $114.87 | 1 |
| , MD | Internal Medicine | Oklahoma City, OK | $114.86 | 1 |
| , MD | Maternal & Fetal Medicine | Frisco, TX | $106.82 | 1 |
| , PA | Physician Assistant | Whitney, TX | $106.82 | 1 |
| , D.O | Specialist | Frisco, TX | $106.82 | 1 |
| , MD | Anatomic Pathology & Clinical Pathology | Plano, TX | $106.82 | 1 |
| , M.D | Specialist | Dallas, TX | $106.82 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $4.1M
Product Information
- Type Device
- Total Payments $4.1M
- Total Doctors 44
- Transactions 271
About Architect i2000SR Analyser System
Architect i2000SR Analyser System is a device associated with $4.1M in payments to 44 healthcare providers, recorded across 271 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2021 to 2021. In 2021, $4.1M was paid across 271 transactions to 44 doctors.
The most common payment nature for Architect i2000SR Analyser System is "Unspecified" ($3.6M, 88.1% of total).
Architect i2000SR Analyser System is associated with 20 research studies, including "CRA Second Amendment-CAD Study" ($687,000).